Skip to main

Xenotransplantation: Pig-to-Human Kidney Transplant

Xenotransplantation: Pig-to-Human Kidney Transplant

Learn more about the latest in Xenotransplantation, Pig-to-Human Kidney Transplant, from the experts in the field.

  • 2:00 PM - 3:00 PM EST
  • Virtual

Speakers: 

  • Tatsuo Kawai, MD, PhD • Professor of Surgery, Harvard Medical School, Boston, MA
  • Robert Montgomery, MD, PhD • H. Leon Pachter, MD Professor of Surgery, Department of Surgery at NYU Grossman School of Medicine, New York, NY

Moderator: 

  • Vineeta Kumar, MD, FAST, FASN • Professor of Medicine, Robert C. Bourge and Cutessa D. Bourge Endowed Professor in Transplant Nephrology, University of Alabama at Birmingham, Heersink School of Medicine, Birmingham, AL

Discussants: 

  • Leonardo Riella, MD, PhD, FAST • Harold and Ellen Danser Endowed Chair in Transplantation, Harvard Medical School, Boston, MA
  • Nicole Ali, MD • Clinical Associate Professor, Department of Medicine at NYU Grossman School of Medicine, New York, NY

Expected Objectives:

  1.  Review lessons learned from pig-to-human kidney transplant cases
  2. Discuss engineering of pigs for human organ transplantation
  3. Compare and contrast how pig versus human kidneys perform in a human recipient
  4. Examine risks and complications in recipients of pig kidneys
     

This topic was developed by the AST Education Committee for the 2024-2025 T3 webinar series with the support of AST's Kidney Pancreas Community of Practice (KPCOP). Learn more about AST's COPs at www.myast.org/cops.

Timely Topics in Transplantation (T3) webinars are $25.00 but free for AST members! To learn more about upcoming T3 webinars and view past T3 archives, visit the T3 webinar series page on the myAST website.

Give Back

Make a difference in the field of transplantation by donating to support our cause.

Give

Sign up for AST eNews

This resource for transplant professionals shares AST news events and top articles in transplantation.

Advertisements

This content was developed independently by AST and supported by a financial contribution from Sanofi